Neuroblastoma Drugs Market To Achieve Significant Growth In The Near Future With Demand, Size, Trend, Segmentation, Growth Opportunities -2023

MFR Research Report Offering Encompasses Different Strategies, Such As Mergers & Acquisitions, Partnerships & Collaborations, Business Expansions, And Product Developments, Adopted By Major Players

PUNE, India - July 11, 2019 /MarketersMedia/ —

Market Highlights

The global neuroblastoma is anticipated to hold a market value of 2.60 billion in 2017 and is expected to grow at a CAGR of 3.7% during the forecast period. Neuroblastoma is a childhood cancer most commonly occurs in children below the age of 5 years.

The neuroblast may cause due to the immature cell growth or mutation in the gene responsible for controlling cell proliferation. The increasing cases of childhood cancer, rising research on neuroblastoma treatment and increasing spending on cancer treatment is expected to drive market growth over the forecast period. According to the American Society of Clinical Oncology (ASCO) April 2018 publication, every year, more than 700 children get diagnosed with neuroblastoma in the US and it is also indicated that neuroblastoma is the most common cancer in children younger than 1 year. It is more commonly found in boys compare to girls. The increasing cases of childhood cancer boost market growth during the forecast period.

Despite the drivers, shortage of trained healthcare specialists and the high cost of this therapy can restrain the market growth over the assessment period.

Request to Get free  the Sample Pages at - https://www.marketresearchfuture.com/sample_request/6555
Key Players

Some of the prominent players in the global neuroblastoma market are United Therapeutics Corp., APEIRON Biologics AG, LUMITOS AG, NANTGE Healthcare, Pfizer Inc., GL Pharm Tech Corporation, Aetna Inc, RxStrategies, Inc., and others.

Segmentation

The global neuroblastoma market has been segmented into diagnostics, treatment, and end user.

The market, on the basis of diagnostics, has been segmented into various tests, MIBG scan, imaging, and biopsy. The tests are further sub-segmented into bone marrow, tissue, urine, and blood.

The market, by treatment, has been segmented into surgery, chemotherapy, radiation therapy, stem cell transplant, immunotherapy, and monoclonal antibody treatment.

On the basis of end user, the global neuroblastoma market has been segmented into hospitals ambulatory surgical centers, diagnostic centers, research centers, and others.

Regional Analysis

Asia-Pacific is expected to be the fastest growing market owing to the increasing children cancer base and increasing developments in the healthcare segment.

Geographically, the Americas is expected to dominate the global neuroblastoma market owing to the presence of well-developed healthcare sector, rising prevalence of infant cancer cases, and growing expenditure for the healthcare sector. Europe is expected to hold the second largest position in the global neuroblastoma market owing to the growing number of child healthcare centers for cancer treatment and raising awareness about the treatment for neuroblastoma.  According to the Cancer Research UK May 2018 publication, around 100 infants are detected with neuroblastoma every year in the UK. This provides favorable backgrounds for the neuroblastoma market to grow.

According to the Neuroblastoma Australia organization October 2018 article, every year approximately 40 cases of neuroblastoma are indicated in Australia due to some unknown genetic problems which will support the market growth.

 Furthermore, the Middle Eastern and African region is expected to account for the least market share in the global market.

Access Report @ https://www.marketresearchfuture.com/reports/neuroblastoma-market-6555
About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Info:
Name: Abhishek Sawant
Email: Send Email
Organization: Market Research Future
Address: Contact:, , Market Research Future, , Office No. 528, Amanora Chambers, , Magarpatta Road, Hadapsar,, , Pune - 411028, , Maharashtra, India, , +1 646 845 9312, , Email: sales@marketresearchfuture.com
Phone: 646845931
Website: https://www.marketresearchfuture.com

Source URL: https://marketersmedia.com/neuroblastoma-drugs-market-to-achieve-significant-growth-in-the-near-future-with-demand-size-trend-segmentation-growth-opportunities-2023/88895456

Source: MarketersMedia

Release ID: 88895456

Latest News

APNewsBreak: NRC looking at reducing inspections at reactors

Jul 17, 2019

WASHINGTON — Nuclear Regulatory Commission staff is recommending that the agency cut back on inspections at the country's nuclear reactors, a cost-cutting move promoted by the nuclear power industry but denounced by opponents as a threat to public safety. The recommendations, made public Tuesday, include reducing the time and scope of some annual inspections at the nation's 90-plus nuclear power plants. Some other inspections would be cut from every two years to every three years. Some of the staff's recommendations would require a vote by the commission, which has a majority of members appointed or reappointed by President Donald Trump,...

The Latest: Iran says it helped a tanker with tow to harbor

Jul 17, 2019

DUBAI, United Arab Emirates — The Latest on tensions in the Persian Gulf amid a crisis between the United States and Iran (all times local): 5:30 a.m. Iran's state-run media is quoting the country's Foreign Ministry spokesman as saying the Islamic Republic helped an oil tanker in the Strait of Hormuz amid U.S. concern that Tehran seized one there. The state-run IRNA news agency early Wednesday quoted Abbas Mousavi as saying Iran towed an unnamed vessel to harbor after it suffered a technical malfunction. However, both the U.S. and the United Arab Emirates, where the tanker is based, say that...

Hawaii protesters vow 'prolonged struggle' against telescope

Jul 17, 2019

MAUNA KEA, Hawaii — Protesters vowed to continue demonstrating against the construction of a giant telescope on top of a mountain some Native Hawaiians consider sacred after they spent the day blocking the road to the project site. About a dozen elders, or kupuna, sat in chairs at the start of the road on Monday, committed to being arrested if need be. Another eight shackled themselves to each other over a grate in the road. They acted after state officials announced they would close the road to the summit of Mauna Kea so they could begin bringing equipment to the...

Planned Parenthood to defy Trump abortion referral rule

Jul 17, 2019

WASHINGTON — Federally funded family planning clinics, including Planned Parenthood, are defying the Trump administration's ban on referring women for abortions, drawing a line against what they say amounts to keeping patients in the dark about legitimate health care options. "We are not going to comply with a regulation that would require health care providers to not give full information to their patients," Jacqueline Ayers, the group's top lobbyist, said in an interview Tuesday. "We believe as a health care provider it is wrong to withhold health care information from patients." The fallout from the confrontation between the Trump administration...

Man pleads guilty in case tied to ex-St. Louis County leader

Jul 17, 2019

ST. LOUIS — A businessman has admitted in federal court that he provided bribes as part of former St. Louis County Executive Steve Stenger's pay-to-play scheme, the fourth person to plead guilty in connection with the crime. John Rallo pleaded guilty Tuesday to three counts of bribery. Sentencing will be Oct. 15. Rallo was indicted days after Stenger, a Democrat, pleaded guilty in May to federal charges for directing county contracts to campaign donors. The indictment cited businesses operated by Rallo. Former Stenger chief of staff Bill Miller and Sheila Sweeney, the woman Stenger appointed to head the county's economic...

Search

Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Contact us: sales@deckbiz.com